HHS, DOD Collaborate with Novavax to Produce Millions of COVID-19 Investigational Vaccine Doses in Commercial-Scale Manufacturing Demonstration Projects

08. July 2020 EHR, EMR, Health, HIPAA 0
The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) today jointly announced a $1.6 billion agreement with Novavax, Inc. of Gaithersburg, Maryland, to demonstrate commercial-scale manufacturing of the company’s COVID-19 investigational vaccine. By funding this manufacturing effort, the federal government will own the 100 million doses of investigational vaccine expected ...

HHS, DOD Collaborate with Regeneron on Large-Scale Manufacturing Demonstration Project of COVID-19 Investigational Therapeutic Treatment

08. July 2020 EHR, EMR, Health, HIPAA 0
The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) today announced an agreement with Regeneron, Inc. of Tarrytown, New York, to demonstrate commercial-scale manufacturing of the company’s COVID-19 investigational anti-viral antibody treatment, REGN-COV2. By funding this manufacturing effort, the federal government will own the doses expected to result from the ...

Assistant Secretary for Health Admiral Brett P. Giroir, M.D., Statement on FDA EUA Approval of the BD Veritor Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2

07. July 2020 EHR, EMR, Health, HIPAA 0
Today, the U.S. Food and Drug Administration granted an Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test BD Veritor Plus System. In response, Assistant Secretary for Health and COVID-19 Testing Coordinator Admiral Brett P. Giroir, M.D., issued the following statement: “The BD Veritor Plus System for rapid detection of SARS-CoV-2 is the ...